Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions
NCT ID: NCT01316627
Last Updated: 2011-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
20 participants
INTERVENTIONAL
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa
NCT06332963
Attention Training and Its Effects on Body Image Disturbance
NCT01110265
A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students
NCT04103606
The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.
NCT05794763
Evaluation of Practical Body Image Therapy for Anorexia Nervosa V1
NCT04064255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Further Evaluation: After the initial telephone screening, potential subjects will meet with the principal investigator, Dr. Eda Gorbis, who will ask the subject to sign an informed consent form (ICF). The research procedures and treatment will be described in detail to the subject and any questions will be answered by the principal investigator. The ICF will be signed by the subject and the principal investigator, agreeing to those procedures in the study that are considered research, acknowledging that their participation is voluntary, and that they have been informed of the risks and benefits of the study. Research procedures include cognitive testing, standardized rating scales, and clinical assessment questionnaires discussed below.
When the ICF is signed, the potential subjects will meet with the study physician, Dr. Kagan, for a comprehensive psychiatric evaluation and physical assessment to confirm a primary diagnosis of BDD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV), and identify any confounding comorbidity, physical health, or medication issues which may or may not preclude their participation in treatment. According to subjects' self-report, those who are currently on medication for their BDD must have a regular prescribing physician who can continue prescribing their medication.
Upon confirmation of inclusion into the study, subjects will then be given appointments for cognitive testing and further clinical assessments by the study independent evaluator. The Mini International Neuropsychiatric Interview for DSM-IV (M.I.N.I.; Sheehan \& Lecrubier et al., 1998) will be used to determine comorbid disorders that are excluded from the study, which will take approximately 45 minutes to complete. The Wechsler Adult Intelligence Scale - Third Edition (WAIS-III; Wechsler 1997), which is an instrument that assesses verbal and nonverbal intellectual functioning, will be used to determine subjects' cognitive capacity, and will take approximately 90-120 minutes to complete.
Assessment Instruments: One week prior to treatment, subjects will be administered a battery of clinical rating scales and questionnaires to determine the severity of their BDD and any secondary symptoms. This same assessment battery will be given immediately following treatment to determine the level of efficacy of each of the two treatment groups. These scales include the Yale-Brown Obsessive-Compulsive Scale Modified for BDD (BDD-YBOCS), Body Dysmorphic Disorder Examination-Self Report (BDDE-SR), BDD Diagnostic Module (BDDDM), Y-BOCS Symptom Checklist, Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Hamilton Rating Scale for Depression (Ham-D), Hamilton Anxiety Rating Scale (HARS), Fixity of Beliefs Questionnaire, Global Assessment of Functioning (GAF), NIMH Global Obsessive-compulsive Scale, Brown Assessment of Beliefs Scale (BABS), Obsessive-Compulsive Inventory (OCI), Obsessive-Compulsive Rating Scale (OCON), Fear Survey Schedule (FSS), and the Revised Willoughby Questionnaire. These will take approximately 90-120 minutes to complete.
Randomization: Following assessment, subjects will be pseudo-randomized into either the mirror retraining treatment group or the crooked mirror treatment group. Pseudo-randomization means that subjects will first be assigned to one of the two groups randomly, then group membership will be remixed if needed to assure that there is no significant between-group difference in pretreatment BDD-YBOCS scores. If possible, groups will also be matched for age and gender.
Intensive Cognitive-Behavioral Therapy: After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crooked Mirror Externalization Therapy
Of recent, the "crooked mirror" externalization therapy, developed by Dr. Eda Gorbis, has been put to use with much success (Gorbis 2004). This method involves the use of crooked or "fun house" mirrors made from highly reflective surfaces that can be bent in different directions, which distort and exaggerate the patient's perceived defects (Gorbis 2005). In turn, this process externalizes or reverses the patient's internalized distorted body image, and allows the patient to habituate to the reflection of the imagined defect that is even more distorted than the internalized image (Rosen et al. 1995).
Crooked Mirror Externalization Therapy
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Mirror Retraining Method
In treating BDD, the cognitive-behavioral technique, "mirror retraining," uses ordinary and/or magnifying mirrors to amplify the supposed defect, which teaches patients to see their appearance in a more holistic way. Since BDD patients tend to only focus on their perceived flaws when looking in the mirror, and tend to think about their flaws in negative terms, in mirror retraining, patients learn how to change their negative evaluations of their appearance into more objective and nonjudgmental descriptions. Generally, this method is designed to intentionally exaggerate anxiety regarding appearance concerns through exposures with mirrors. However, using exclusively ordinary and/or magnifying mirrors does not address the internal distorted image that many patients with BDD experience (Rosen et al. 1995, Osman et al. 2004, Veale 2004).
Mirror Retraining Method
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Crooked Mirror Externalization Therapy
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Mirror Retraining Method
After subjects complete the pre-treatment assessments, the study therapist will meet with participants to design their treatment program. Treatment will be conducted every day for 15 days, Monday through Friday, for 90-minute sessions. In addition, as a part of therapy, subjects will complete homework assignments daily. Intensive CBT for BDD is done in the form of Exposure and Response Prevention (ERP) with either the mirror retraining method or the crooked mirror externalization therapy. This involves prolonged and repeated exposures to images of the perceived defects, and prevention of ritualistic behavior (e.g., camouflaging with cosmetics, skin-picking, etc.).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets DSM-IV criteria for BDD
* Baseline 12-item BDD-YBOCS score \>15
* Baseline 33-item BDDE score \> 99
* Baseline 3-item BDDDM score \> 9
* IQ \> 90
* English-speaking
* No changes in psychotropic medication during or 12 weeks prior to study
Exclusion Criteria
* No co-morbid psychiatric contraindications (psychosis, bipolar disorder, Tourette's or other tic disorder, panic disorder, PTSD, ADHD, anorexia nervosa, bulimia)
* Current suicidality
* Primary diagnosis of OCD, depression, or substance abuse
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Westwood Institute for Anxiety Disorders, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UCLA PSYCHIATRY/BIOBEHAVIORAL SCIENCES
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eda Gorbis, PhD, LMFT
Role: PRINCIPAL_INVESTIGATOR
UCLA - DEPARTMENT OF PSYCHIATRY/BIOBEHAVIORAL SCIENCES
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westwood Institute for Anxiety Disorders, Inc.
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB#G06-05-061-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.